PHARNEXT (EPA:ALPHA) Pharnext: Findings From ‘Real-World’ Digital Lifestyle Study, CMT&Me, on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A Published in the Journal of Clinical Neuromuscular Disease
Transparency directive : regulatory news
14/09/2022 08:31